giovedì, 13 agosto 2026

Notizie AIOM – anno XIV n. 588

Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

BRAF mutations act as an oncogenic driver via the mitogen-activated protein kinase (MAPK) pathway in non-small cell lung cancer (NSCLC). BRAF inhibition has shown antitumour activity in patients with BRAFV600E-mutant NSCLC. Dual MAPK pathway inhibition with BRAF and MEK ...
Leggi tutto

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

Treatment with an aromatase inhibitor for 5 years as up-front monotherapy or after tamoxifen therapy is the treatment of choice for hormone-receptor–positive early breast cancer in postmenopausal women. Extending treatment with an aromatase inhibitor to 10 years may ...
Leggi tutto

Tumore della tiroide: ok dell’Aifa per lenvatinib

AIFA ha autorizzato la rimborsabilità di lenvatinib nel trattamento di pazienti con carcinoma tiroideo differenziato e refrattario allo iodio radioattivo (RR-DTC). Il parere dell’Agenzia regolatoria italiana è basato sui risultati dello studio SELECT ...
Leggi tutto

17 giugno 2016 – Abuso di farmaci oppioidi: una strategia regolatoria globale per mitigare il fenomeno

Locally Advanced Pancreatic Cancer

To provide evidence-based recommendations to oncologists and others for treatment of patients with locally advanced, unresectable pancreatic cancer. ASCO convened an Expert Panel of medical oncology, radiation oncology, surgical oncology, gastroenterology, palliative care, ...
Leggi tutto

Potentially Curable Pancreatic Cancer

To provide evidence-based recommendations to oncologists and others on potentially curative therapy for patients with localized pancreatic cancer. ASCO convened a panel of medical oncology, radiation oncology, surgical oncology, palliative care, and advocacy experts and ...
Leggi tutto

Metastatic Pancreatic Cancer

To provide evidence-based recommendations to oncologists and others for the treatment of patients with metastatic pancreatic cancer. ASCO convened an expert panel of medical oncology, radiation oncology, surgical oncology, gastroenterology, palliative care, and advocacy ...
Leggi tutto

13 giugno 2016 – Condivisione dei dati provenienti dalle sperimentazioni cliniche: l’importanza di un approccio globale

13 giugno 2016 – Operazione PANGEA IX

14 giugno 2016 – L’innovazione sostenibile, dal paziente al sistema